<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2109222628
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LODIPAM 2.5 mg Film-Coated Tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMLODIPINE BESILATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        22.25
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SAUDI PHARMACEUTICAL INDUSTRIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1023]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C08CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The name of your medicine is Lodipam. It contains the active ingredient Amlodipine besylate.<br />Lodipam is used to treat high blood pressure. Everyone has blood pressure, This pressure helps to circulate the blood all around your body. Your blood pressure may be different at different times of the day, depending on how busy or worried you are. You have hypertension (high blood pressure) when your blood pressure stays higher than is needed, even when you are calm and relaxed.<br />There are usually no symptoms of hypertension. The only way of knowing that you have hypertension is to have your blood pressure checked on a regular basis. If high blood pressure is not treated it can lead to serious health problems. You may feel fine and have no symptoms, but eventually hypertension can cause stroke, heart disease and kidney failure.<br />Lodipam helps to lower your blood pressure.<br />Lodipam is also used to treat angina pectoris. Angina is caused by a shortage of the supply of oxygen to the heart and is characterized by a painful and uncomfortable feeling in the chest.<br />This feeling often spreads to the arms or neck, and sometimes also to the shoulders and back.<br />Lodipam is not for the relief of a sudden attack of angina. If such an attack occurs, you should take other medication that your doctor will have given to you.<br />Your doctor may have prescribed Lodipam for another reason. Ask your doctor if you have any questions about why Lodipam was prescribed for you.<br />Lodipam is available only with a doctor&rsquo;s prescription.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Lodipam</strong></p><ul><li>If you are allergic (hypersensitive) to amlodipine, or any of the other ingredients of this medicine listed in section 6, or to any other calcium antagonists. This may be itching, reddening of the skin or difficulty in breathing.</li><li>If you have severe low blood pressure (hypotension).</li><li>If you have narrowing of the aortic heart valve (aortic stenosis) or cardiogenic shock (a condition where your heart is unable to supply enough blood to the body).</li><li>If you suffer from heart failure after a heart attack.</li></ul><p><strong>Warnings and precautions :</strong><br />Talk to your doctor or pharmacist before taking Lodipam.<br />You should inform your doctor if you have or have had any of the following conditions:</p><ul><li>Recent heart attack</li><li>Heart failure</li><li>Severe increase in blood pressure (Hypertensive crisis)</li><li>Liver disease</li><li>You are elderly and your dose needs to be increased</li></ul><p><strong>Children and adolescents :</strong><br />Lodipam has not been studied in children under the age of 6 years. Lodipam should only be used for hypertension in children and adolescents from 6 years to 17 years of age. For more information, talk to your doctor.</p><p><strong>Other medicines and Lodipam :</strong><br />Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.<br />Lodipam may affect or be affected by other medicines, such as:</p><ul><li>Ketoconazole, Itraconazole (anti-fungal medicines)</li><li>Ritonavir, Indinavir, Nelfinavir (so called protease inhibitors used to treat HIV)</li><li>Rifampicin, Erythromycin, Clarithromycin (antibiotics)</li><li>Hypericum Perforatum (St. John&rsquo;s Wort)</li><li>Verapamil, Diltiazem (heart medicines)</li><li>Dantrolene (infusion for severe body temperature abnormalities)</li><li>Simvastatin (cholesterol lowering medicine)</li><li>Cyclosporine (an immunosuppressant)</li></ul><p>Lodipam may lower your blood pressure even more if you are already taking other medicines to treat your high blood pressure.</p><p><strong>Lodipam with food and drink :</strong><br />Grapefruit juice and grapefruit should not be consumed by people who are taking Lodipam. This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active ingredient amlodipine, which can cause an unpredictable increase in the blood pressure lowering effect of Lodipam.</p><p><strong>Pregnancy and breast-feeding :</strong><br /><strong>Pregnancy</strong><br />The safety of amlodipine in human pregnancy has not been established. If you think you might be pregnant, or are planning to get pregnant, you must tell your doctor before you take Lodipam.<br /><strong>Breast-feeding</strong><br />It is not known whether amlodipine is passed into breast milk. If you are breast-feeding or about to start breast-feeding you must tell your doctor before taking Lodipam. Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Driving and using machines:</strong><br />Lodipam may affect your ability to drive or use machines. If the tablets make you feel sick, dizzy or tired, or give you a headache, do not drive or use machines and contact your doctor immediately.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.<br />The recommended initial dose is Lodipam 5 mg once daily. The dose can be increased to Lodipam 10 mg once daily.<br />This medicine can be used before or after food and drinks. You should take this medicine at the same time each day with a drink of water.<br />Do not take Lodipam with grapefruit juice.</p><p><strong>Use in children and adolescents :</strong><br />For children and adolescents (6-17 years old), the recommended usual starting dose is 2.5 mg a day. The maximum recommended dose is 5 mg a day.<br />Lodipam 5 mg tablets can be divided into halves to provide a 2.5 mg dose. It is important to keep taking the tablets. Do not wait until your tablets are finished before seeing your doctor.</p><p><strong>If you take more Lodipam than you should :</strong><br />Taking too many tablets may cause your blood pressure to become low or even dangerously low. You may feel dizzy, light headed, faint or weak. If blood pressure drop is severe enough shock can occur. Your skin could feel cool and clammy and you could lose consciousness.<br />Seek immediate medical attention if you take too many Lodipam tablets.</p><p><strong>If you forget to take Lodipam :</strong><br />Do not worry. If you forget to take a tablet, leave out that dose completely. Take your next dose at the right time. Do not take a double dose to make up for a missed dose.</p><p><strong>If you stop taking Lodipam :</strong><br />Your doctor will advise you how long to take this medicine. Your condition may return if you stop using this medicine before you are advised. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br /><strong>The following very common side effect has been reported.</strong><br />If this causes you problems or if it lasts for more than one week, you should contact your doctor.</p><p><strong>Very common: may affect more than 1 in 10 people</strong></p><ul><li>Ankle swelling (oedema) The following common side effects have been reported. If any of these cause you problems or if they last for more than one week, you should contact your doctor.</li></ul><p><strong>Common: may affect up to 1 in 10 people</strong></p><ul><li>Headache, dizziness, sleepiness (especially at the beginning of treatment)</li><li>Palpitations (awareness of your heart beat), flushing</li><li>Abdominal pain, feeling sick (nausea)</li><li>Altered bowel habits, diarrhoea, constipation, indigestion,</li><li>Tiredness, weakness</li><li>Visual disturbances, double vision</li><li>Muscle cramps</li></ul><p>Other side effects that have been reported include the following list. If any of these get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.<br /><strong>Uncommon: may affect up to 1 in 100 people</strong></p><ul><li>Mood changes, anxiety, depression, sleeplessness</li><li>Trembling, taste abnormalities, fainting, weakness</li><li>Numbness or tingling sensation in your limbs, loss of pain sensation</li><li>Ringing in the ears</li><li>Low blood pressure</li><li>Sneezing/running nose caused by inflammation of the lining of the nose (rhinitis)</li><li>Cough</li><li>Dry mouth, vomiting (being sick)</li><li>Hair loss, increased sweating, itchy skin, red patches on skin, skin discolouration</li><li>Disorder in passing urine, increased need to urinate at night, increased number of times of passing urine</li><li>Inability to obtain an erection, discomfort or enlargement of the breasts in men</li><li>Pain, feeling unwell</li><li>Joint or muscle pain, back pain</li><li>Weight increase or decrease</li></ul><p><strong>Rare: may affect up to 1 in 1,000 people</strong></p><ul><li>Confusion</li></ul><p><strong>Very rare: may affect up to 1 in 10,000 people</strong></p><ul><li>Decreased numbers of white blood cells, decrease in blood platelets which may result in unusual bruising or easy bleeding (red blood cell damage)</li><li>Excess sugar in blood (hyperglycaemia)</li><li>A disorder of the nerves which can cause weakness, tingling or numbness</li><li>Swelling of the gums</li><li>Abdominal bloating (gastritis)</li><li>Abnormal liver function, inflammation of the liver (hepatitis), yellowing of the skin (jaundice), liver enzyme increase which may have an effect on some medical tests</li><li>Increased muscle tension</li><li>Inflammation of blood vessels, often with skin rash</li><li>Sensitivity to light</li><li>Disorders combining rigidity, tremor, and/or movement disorders</li></ul><p><strong>Reporting of side effects</strong><br />If you get any side effects, talk to your doctor or pharmacist or nurse. Above information based on literature survey and our study<br />Kingdom of Saudi Arabia : info@saudi-pharma.net</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not store above 30&deg;C.<br />Do not take tablets after the expiry date<br />Store in the original package, in order to protect from moisture</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>The active substance is amlodipine (as Amlodipine besylate). Each tablet contains either 2.5 mg, 5mg or 10mg of the active substance</li><li>The other ingredients are. Microcrystalline cellulose, anhydrous calcium hydrogen phosphate, sodium starch glycolate, magnesium stearate, Hypromellose, Titanium dioxide, Polyethylene glycol.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Lodipam 2.5mg, 5mg, and 10mg tablets are Almost-white, octagonal shape film coated tablets. Pack size is 30 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Saudi Pharmaceutical Industries,<br />P.O.Box No.: 355127,Riyadh 11383,Kingdom of Saudi Arabia.<br />Tel: (+96611) 2650450, 2650354,Fax: (+96611) 2650383<br />For any information about this medicine please contact<br />Email.:info@saudi-pharma.net, marketing@saudi-pharma.net</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                12/2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>اسم الدواء الخاص بك هو لوديبام. أنه يحتوي على المادة الفعالة بيزيلات أملوديبين.<br />يستخدم لوديبام لعلاج ارتفاع ضغط الدم. كل شخص لديه ضغط دم، وهذا الضغط يساعد على سريان الدم في جميع أنحاء الجسم. قد يكون ضغط الدم لديك مختلف في أوقات مختلفة من اليوم، وذلك&nbsp; اعتماداً على مدى انشغالك أو قلقك.<br />إذا كنت تعاني من فرط ضغط الدم (ارتفاع ضغط الدم) وعندما يبقى ضغط الدم لديك أعلى مما هو مطلوب، حتى عندما تكون هادئ أو مرتاح.<br />عادة ما تكون هناك أعراض لارتفاع ضغط الدم. والطريقة الوحيدة لمعرفة أن لديك ارتفاع في ضغط الدم هو أن يتم فحص ضغط دمك بشكل منتظم. إذا لم يتم علاج ارتفاع ضغط الدم فإن ذلك يمكن أن يؤدي إلى مشاكل صحية خطيرة.<br />قد تشعر أنك على ما يرام وليس هناك أي أعراض، ولكن في نهاية المطاف فإن ارتفاع ضغط الدم يمكن أن يسبب السكتة الدماغية وأمراض القلب والفشل الكلوي.<br />لوديبام يساعد على خفض ضغط الدم.<br />يستخدم لوديبام أيضا لعلاج الذبحة الصدرية.&nbsp; وتحدث الذبحة الصدرية بسبب نقص إمدادات الأوكسجين إلى القلب ويمكن تمييزها بحدوث شعور مؤلم وغير مريح في الصدر. هذا الشعور غالبا ما ينتشر إلى الذراعين أو الرقبة، وأحيانا أيضا إلى الكتفين والظهر.<br />لوديبام لا يستخدم للتخفيف من هجوم مفاجئ من الذبحة الصدرية. في حال حدوث مثل هذا الهجوم، يجب أن تأخذ أدوية أخرى تم وصفها لك من خلال طبيبك.<br />طبيبك قد وصف لوديبام لسبب آخر. اسأل طبيبك لماذا تم وصف لوديبام لك.<br />لوديبام لا بتم صرفه إلا بوصفة طبيب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تأخذ لوديبام</strong></p><ul dir="rtl"><li>إذا كنت تعاني من حساسية ضد الأملوديبين، أو أي من المكونات الأخرى من هذا الدواء المدرجة في البند 7، أو إلى أي مضادات الكالسيوم الأخرى. قد يكون هذا على شكل حكة، احمرار الجلد أو صعوبة في التنفس.</li><li>إذا كان لديك ضغط الدم المنخفض الشديد (انخفاض ضغط الدم).</li><li>إذا كان لديك ضيق في صمام القلب الأبهري (تضيق الأورطي) أو صدمة قلبية (الحالة التي يكون فيها قلبك غير قادر على توفير ما يكفي من الدم إلى الجسم).</li><li>إذا كنت تعاني من قصور في القلب بعد نوبة قلبية.</li></ul><p dir="rtl"><strong>التحذيرات والاحتياطات:</strong><br />تحدث إلى طبيبك أو الصيدلي قبل استخدام لوديبام.<br />يجب إبلاغ الطبيب إذا كنت تعاني أو كان لديك في السابق أي من الحالات التالية:</p><ul dir="rtl"><li>نوبة قلبية حديثة</li><li>فشل القلب</li><li>الزيادة الشديدة في ضغط الدم (نوبة فرط الضغط)</li><li>أمراض الكبد</li><li>أنت من كبار السن وبحاجة إلى زيادة في الجرعة</li></ul><p><strong>الأطفال والمراهقين:</strong><br />لم بتم عمل بحث حول لوديبام في الأطفال الذين تقل أعمارهم عن 6 سنوات.&nbsp;لوديبام يجب أن يستخدم فقط لارتفاع ضغط الدم لدى الأطفال والمراهقين من 6 سنوات إلى 17 سنة من العمر. لمزيد من المعلومات، تحدث الى الطبيب.</p><p><strong>الأدوية الأخرى ولوديبام:</strong><br />أخبر طبيبك أو الصيدلي إذا كنت تأخذ أو قد أخذت مؤخرا أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية.<br />لوديبام قد يؤثر أو يتأثر بأدوية أخرى، مثل:</p><ul dir="rtl"><li>الكيتوكونازول، الايتراكونازول (الأدوية المضادة للفطريات)</li><li>ريتونافير، عقار أندينافير، نلفينافير (ما يسمى مثبطات الأنزيم البروتيني المستخدمة لعلاج فيروس نقص المناعة البشرية)</li><li>ريفامبيسين، الاريثروميسين، كلاريثروميسين (المضادات الحيوية)</li><li>بيرفوراتوم (نبتة سانت جون)</li><li>فيراباميل، ديلتيازيم (أدوية القلب)</li><li>دانترولين (ضخ عند حالات درجة حرارة الجسم الشديدة)</li><li>سيمفاستاتين (علاج خفض الكولسترول)</li><li>السيكلوسبورين (للمناعة)</li></ul><p>لوديبام قد يخفض ضغط الدم لديك أكثر من ذلك إذا كنت تأخذ بالفعل أدوية أخرى لعلاج ارتفاع ضغط الدم.</p><p><strong>لوديبام مع الطعام والشراب:</strong><br />يجب عدم تناول الجريب فروت أو عصير الجريب فروت من قبل الأشخاص الذين يستخدمون لوديبام. وذلك لأن الجريب فروت وعصير الجريب فروت يمكن أن يؤدي إلى زيادة في مستويات الدم من المادة الفعالة أملوديبين، الذي يمكن أن يسبب زيادة غير متوقعة في انخفاض ضغط الدم المتأثر بلوديبام.</p><p><strong>الحمل والرضاعة الطبيعية:<br />فترة الحمل</strong><br />لم تثبت سلامة أملوديبين في فترة الحمل البشري. إذا كنت تعتقدين أنك قد تكونين حاملاً، أو تخططين للحمل، يجب أن تخبري طبيبك قبل أن تأخذي لوديبام<br /><strong>الرضاعة الطبيعية</strong><br />ومن غير المعروف ما إذا كان يتم تمرير أملوديبين في حليب الثدي. إذا كنت تقومين بالرضاعة الطبيعية أو على وشك أن تبدئي الرضاعة الطبيعية يجب أن تخبري طبيبك قبل استخدام لوديبام.<br />اسأل طبيبك أو الصيدلي للحصول على المشورة قبل استخدام أي دواء.</p><p><strong>القيادة واستخدام الآليات:</strong><br />لوديبام قد يؤثر على القدرة على القيادة أو استخدام الآلات. إذا كانت الأقراص تجعلك تشعر بالغثيان، بالدوار أو التعب، أو تسبب لك الصداع، لا تقد أو تستخدم الآلات واتصل بطبيبك فورا ً.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>اتبع دائما ً الجرعة الموصى بها من قبل طبيبك أو الصيدلي. استشر طبيبك أو الصيدلي إذا لم تكن متأكدا ً.<br />الجرعة الأولية الموصى بها هي لوديبام 5 ملغ مرة واحدة يوميا ً. ويمكن زيادتها إلى 10 ملغ مرة واحدة يوميا ً.<br />يمكن استخدام هذا الدواء قبل أو بعد الطعام والمشروبات. يجب أن تأخذ هذا الدواء في نفس الوقت كل يوم مع شربة ماء.<br />لا تأخذ لوديبام مع عصير الجريب فروت.</p><p><strong>استخدام في الأطفال والمراهقين:</strong><br />بالنسبة للأطفال والمراهقين (6-17 سنة)، فإن الجرعة الموصى بها هي البداية المعتادة 2.5 ملغ يوميا ً. الجرعة القصوى الموصى بها هي 5 ملغ في اليوم.<br />ويمكن تقسيم أقراص لوديبام 5 ملغ الى نصفين لتوفير جرعة 2.5 ملغ. من المهم الحفاظ على أخذ أقراص لذاك لا تنتظر حتى انتهاء الأقراص حتى ترى الطبيب.</p><p><strong>إذا تناولت كمية لوديبام أكثر مما يجب:</strong><br />أخذ الكثير من الأقراص قد يسبب انخفاض في ضغط الدم وقد يصبح منخفض بشكل خطير. قد تشعر بالدوار، مصاب بدوار الرأس، خفيف أو ضعيفة.&nbsp;&nbsp;إن انخفاض ضغط الدم الحاد يمكن أن يسبب صدمة إلى حد ما. يمكن أن تشعر بأن جلدك بارد ورطب وقد تفقد وعيك.<br />أطلب العناية الطبية الفورية إذا كنت قد أخذت الكثير من أقراص لوديبام.</p><p><strong>إذا كنت قد نسيت أن تأخذ لوديبام:</strong><br />لا تقلق. إذا كنت قد نسيت أن تأخذ القرص، أترك تلك الجرعة تماما ً. خذ الجرعة التالية في الوقت المناسب. لا تأخذ جرعة مضاعفة لتعويض الجرعة المنسية.</p><p><strong>إذا توقفت عن تناول لوديبام:</strong><br />طبيبك سوف ينصحك لكم من الوقت يجب أن تأخذ هذا الدواء. قد تتراجع حالتك إذا توقفت عن استخدام هذا الدواء قبل أن ينصح الطبيب بذلك.&nbsp;إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن لهذا الدواء أن يسبب آثارا جانبية، على الرغم من أن ذلك قد لا يحصل للجميع.<br /><strong>وقد تم الإبلاغ عن الآثار الجانبية الشائعة التالية.</strong><br />إذا كان أي من هذه تسبب لك مشاكل أو إذا استمرت لأكثر من أسبوع واحد، وجب عليك الاتصال بطبيبك.</p><p><strong>شائع جدا ً: قد تؤثر على أكثر من 1 لكل 10 أشخاص</strong></p><ul dir="rtl"><li>تورم الكاحل (وذمة)&nbsp;</li></ul><p dir="rtl"><strong>الآثار الجانبية الشائعة: قد يؤثر على ما يصل إلى 1 لكل 10 أشخاص</strong></p><ul dir="rtl"><li>الصداع، والدوخة، والنعاس (وخصوصا ً في بداية العلاج)</li><li>الخفقان (التنبه بضربات القلب الخاص بك)، التهيج</li><li>ألم في البطن، والشعور بالمرض (الغثيان)</li><li>تغير حالة الأمعاء، الإسهال، والإمساك، وعسر الهضم،</li><li>التعب، والضعف</li><li>اضطرابات سمعية، الرؤية المزدوجة</li><li>تقلصات العضلات</li></ul><p>وتشمل الآثار الجانبية الأخرى التي تم الإبلاغ عنها في القائمة التالية. إذا كان أي من هذه الآثار خطير، أو إذا لاحظت أي آثار جانبية غير المذكورة في هذه النشرة، يرجى إخبار الطبيب أو الصيدلي.<br /><strong>الآثار الجانبية غير الشائع: قد يؤثر على ما يصل إلى 1 لكل 100 شخص</strong></p><ul dir="rtl"><li>تغيرات المزاج، والقلق، والاكتئاب، والأرق</li><li>ارتجاف، اضطراب في التذوق، الاغماء، والضعف</li><li>الإحساس بالخدر أو الوخز في أطرافك، وفقدان الإحساس بالألم</li><li>الرنين في الأذنين</li><li>انخفاض ضغط الدم</li><li>العطس / سيلان الأنف الناجم عن التهاب بطانة الأنف (التهاب الأنف)</li><li>السعال</li><li>جفاف الفم والقيء&nbsp;</li><li>فقدان الشعر، زيادة التعرق، حكة في الجلد، والبقع الحمراء على الجلد، تغير لون الجلد</li><li>اضطراب في التبول، وزيادة الحاجة للتبول ليلاً، وزيادة عدد مرات التبول</li><li>عدم القدرة على الانتصاب، وعدم الراحة والتثدي لدى الرجال</li><li>ألم، والشعور بالإعياء</li><li>آلام المفاصل أو العضلات، وآلام الظهر</li><li>زيادة أو نقصان الوزن</li></ul><p dir="rtl"><strong>الآثار الجانبية النادرة: قد يؤثر على ما يصل إلى 1 لكل 1000 شخص</strong></p><ul dir="rtl"><li>الارتباك</li></ul><p><strong>الآثار الجانبية النادرة جدا ً: قد يؤثر على ما يصل إلى 1 لكل 10000شخص</strong></p><ul dir="rtl"><li>انخفاض عدد خلايا الدم البيضاء، وانخفاض في الصفائح الدموية والتي قد ينتج عنها&nbsp;&nbsp;&nbsp; كدمات غير عادية أو سهلة النزيف (تلف خلايا الدم الحمراء)</li><li>زيادة السكر في الدم (فرط سكر الدم)</li><li>اضطراب في الأعصاب والذي يمكن أن يسبب ضعف، وخز أو خدر</li><li>تورم اللثة</li><li>الانتفاخ في البطن (التهاب المعدة)</li><li>وظائف الكبد غير الطبيعية، والتهاب الكبد (التهاب الكبد)، اصفرار الجلد (اليرقان) وزيادة انزيم الكبد التي قد يكون لها تأثير على بعض الفحوصات الطبية</li><li>زيادة توتر العضلات</li><li>التهاب الأوعية الدموية، وغالبا ً مع طفح جلدي</li><li>الحساسية للضوء</li><li>اضطرابات تشمل التيبس، الارتعاش، و / أو اضطرابات الحركة</li></ul><p dir="rtl"><strong>الإبلاغ عن الآثار الجانبية</strong><br />إذا حدث لك أي آثار جانبية، تحدث مع طبيبك أو الصيدلي أو الممرضة. المعلومات السابقة استنادا ً إلى استطلاعنا ودراستنا<br />المملكة العربية السعودية: info@saudi-pharma.net</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ الدواء بعيداً عن بصر ومتناول الأطفال.</p><p>لا يخزن فوق 30 درجة مئوية.</p><p>لا تستخدم الأقراص بعد تاريخ انتهاء الصلاحية يخزن في العلبة الأصلية، من أجل الحماية من الرطوبة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul dir="rtl"><li>المادة الفعالة هي أملوديبين (على هيئة أملوديبين بيزيلات).&nbsp;كل قرص يحتوي إما على 2.5 ملغ ،5 ملغ أو 10 ملغ من المادة الفعالة</li><li>المكونات الأخرى. ميكروكريستالين السيلولوز، فوسفات الكالسيوم اللامائية، نشا غليكولات الصوديوم، ستيرات المغنيسيوم، هايبروميللوس، وثاني أكسيد التيتانيوم، والبولي إيثلين جليكول.</li></ul>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>لوديبام 2.5 ملغ ،5 ملغ أو 10 ملغ أقراص بيضاء إلى الأبيض اللؤلؤي، أقراص مثمنة الشكل مغلفة بطبقة رقيقة. حجم العبوة هو 30 قرص</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة السعودية للصناعات الصيدلانية<br />صندوق البريد رقم: 355127، الرياض 11383، المملكة العربية السعودية.<br />هاتف: 2650450، 2650354 (96611+)<br />فاكس: 2650383 (96611+)<br />للحصول على أي معلومات عن هذا الدواء يرجى الاتصال البريد الإلكتروني: info@saudi-pharma.net</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            12/2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lodipam 2.5mg film coated tablets
Lodipam 5mg film coated tablets
Lodipam 10mg film coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film coated tablet contains Amlodipine besylate equivalent to 2.5mg Amlodipine.
Each film coated tablet contains Amlodipine besylate equivalent to 5mg Amlodipine.
Each film coated tablet contains Amlodipine besylate equivalent to 10mg Amlodipine.
Excipients:
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablet.
2.5mg tablets: Almost white colored film coated octagonal shaped tablet embossed with number “S125”
5mg tablets: Almost white colored film coated octagonal shaped tablet embossed with number “S123” with tablet breaker score.
10mg tablets: Almost white colored film coated octagonal shaped tablet embossed with number “S122” with tablet breaker score.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypertension<br />Chronic stable angina pectoris<br />Vasospastic (Prinzmetal&rsquo;s) angina</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Adults<br />For both hypertension and the usual initial dose is 5 mg Lodipam once daily which may be increased to a maximum dose of 10 mg depending on the individual patient&rsquo;s response.<br />In hypertensive patients Lodipam has been used in combination with a thiazide diuretic, alpha blocker, beta blocker, or an angiotension converting enzyme inhibitor. For angina, Lodipam may be used as monotherapy or in combination with other antianginal medicinal products in patients with angina that is refractory to nitrates and/or to adequate doses of beta blockers.<br />No dose adjustment of Lodipam is required upon concomitant administration of thiazide diuretics, beta blockers, and angiotension-converting enzyme inhibitors.</p><p><strong>Special populations</strong><br /><strong>Elderly</strong><br />Lodipam used at similar doses in elderly or younger patients is equally well tolerated. Normal dosage regimens are recommended in the elderly, but increase of the dosage should take place with care (see sections 4.4 and 5.2).</p><p><strong>Hepatic impairment</strong><br />Dosage recommendation have not been established in patients with mild to moderate hepatic impairment; therefore dose selection should be cautious and should start at the lower end of the dosing range (see sections 4.4 and 5.2 the pharmacokinetic of Amlodipine have not been studied in severe hepatic impairment. Amlodipine should be initiated at the lowest dose and titrated slowly in patients with severe hepatic impairment.</p><p><strong>Renal impairment</strong><br />Change in Amlodipine plasma concentrations are not correlated with degree of renal impairment, therefore the normal dosage is recommended. Amlodipine is not dialyzable.</p><p><strong>Pediatric population</strong><br />Children and adolescents with hypertension from 6years to 17 years of age The recommended antihypertensive oral dose in pediatric patients age 6-17 years is 2.5 mg once daily as a starting dose, up-titrated to 5mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in pediatric patients (see sections 5.1and 5.2)</p><p>Doses of Amlodipine 2.5 mg are not possible with this medicinal product.</p><p>Children under 6years old<br />No data are available.</p><p>Method of administration<br />Oral administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amlodipine is contraindicated in patients with:
Hypersensitivity to dihydropyridine derivatives, Amlodipine or to any of the excipients.
Severe hypotension.
Shock (including cardiogenic shock).
Obstruction of the outflow tract of the left ventricle (e.g., high grade aortic stenosis).
Haemodynamically unstable heart failure after acute myocardial infarction.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety and efficacy of Amlodipine in hypertensive crisis has not been established.</p><p>Patients with cardiac failure<br />Patients with heart failure should be treated with caution. In a long-term, placebo controlled study in Patients with severe heart failure (NYHA class III and IV) the reported incidence of pulmonary oedema was higher in the Amlodipine treated group in the placebo group (see section 5.1).</p><p>Calcium channel blockers, including Amlodipine, should be used with caution in patients with congestive heart failure, as they may increase the risk of future cardiovascular events and mortality.</p><p>Use in patients with impaired hepatic function<br />The half life of Amlodipine is prolonged and AUC values are higher in patients with impaired liver function; dosage recommendations have not been established. Amlodipine should therefore be initiated at the lower end of the dosing range and caution should be used, both on initial treatment and when increasing the doses. Slow dose titration and careful monitoring may be required in patients with severe hepatic impairment.</p><p>Use in elderly patients<br />In the elderly increase of the dosage should take place with care (see sections 4.2 and 5.2).</p><p>Use in renal failure<br />Amlodipine may be used in such patients at normal doses. Changes in Amlodipine plasma concentrations are not correlated with degree of renal impairment. Amlodipine is not dialyzable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects of other medicinal products on Amlodipine<br />CYP3A4 inhibitors: Concomitant on Amlodipine with strong or moderate CYP3A4 inhibitors (protease inhibitors, azole antifungals, macrolides like erythromycin or clarithromycin, verapamil or diltiazem) may give rise to significant increase in Amlodipine exposure. The clinical translation of these PK variations may be more pronounced in the elderly. Clinical monitoring and dose adjustment may thus be required.</p><p>CYP3A4 inducers: there is no data available regarding the effect of CYP3A4 inducers on Amlodipine. The concomitant use of CYP3A4 inducers (e.g., rifampicin, hypericcum) may give a lower plasma concentration of Amlodipine. Amlodipine should be use with caution together with CYP3A4 inducers.</p><p>Administration of Amlodipine with grapefruit or grapefruit juice is not recommended as bioavailability may be increased in some patients resulting in increased blood pressure lowering effects.</p><p>Dantrolene (infusion): in animals, lethal ventricular fibrillation and cardiovascular collapse are observed in association with hyperkalemia after administration of verapamil and intravenous dantrolene. Due to risk of hyperkalemia, it is recommended that the coadministration of calcium channel blockers such as Amlodipine be avoided in patients susceptible to malignant hyperthermia and in the management of malignant hyperthermia.</p><p>Effects of Amlodipine on other medicinal products<br />The blood pressure lowering effects of Amlodipine adds to the blood pressure-lowering effects of other medicinal products with antihypertensive properties.</p><p>In clinical interaction studies, Amlodipine did not affect the pharmacokinetics of atorvastatin, digoxin, warfarin or cyclosporine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />The safety of Amlodipine in human pregnancy has not been established.<br />In animal studies, reproductive toxicity was observed at high doss (see section 5.3).<br />Use in pregnancy is only recommended when there is no safer alternative and when the disease itself carries greater risk for the mother and fetus.</p><p>Breast-feeding<br />It is not known whether Amlodipine is excreted in breast milk. A decision on whether to Continue/discontinue breast-feeding or to continue/discontinue therapy with Amlodipine should be made taking into account the benefit of breast-feeding to the child and the benefit of Amlodipine therapy to the mother.</p><p>Fertility<br />Reversible biochemical changes in the head of spermatozoa have been reported in some patients treated by calcium channel blockers. Clinical data are insufficient regarding the potential effects of Amlodipine on fertility. In one rat study, adverse effects were found on male fertility (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Amlodipine can have minor or moderate influence on the ability to drive and use machines. If patients taking Amlodipine suffer from dizziness, headache, fatigue or nausea the ability to react may be impaired. Caution is recommended especially at the start of treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>a) Summary of the safety profile<br />The most commonly reported adverse reactions during treatment are somnolence, dizziness, headache, palpitations, flushing, abdominal pain, nausea, ankle swelling, oedema and fatigue.</p><p>b) Tabulated list of adverse reactions<br />The following adverse have been observed and reported during treatment with Amlodipine with the following frequencies: Very common (&ge;1/10); common (&ge;1/100to &lt;1/10); uncommon (&ge;1/1,000 to &ge;1/100); rare (&ge;1/10,000); very rare (&ge;1/10,000).</p><p>Within each frequency grouping, adverse reactions are presented in order of decreasing<br />seriousness.</p><table border="1" cellspacing="1" cellpadding="1" style="width:1097px"><tbody><tr><td style="text-align:center; vertical-align:middle; width:294px"><strong>System organ class</strong></td><td style="text-align:center; vertical-align:middle; width:78px"><strong>Frequency</strong></td><td style="text-align:center; vertical-align:middle; width:722px"><strong>Adverse reactions</strong></td></tr><tr><td style="width:294px"><strong>Blood and lymphatic system disorders</strong></td><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">Leukocytopenia, thrombocytopenia</td></tr><tr><td style="width:294px"><strong>Immune system disorders</strong></td><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">Allergic reactions</td></tr><tr><td style="width:294px"><strong>Metabolism and nutrition disorders</strong></td><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">Hyperglycaemia</td></tr><tr><td rowspan="2" colspan="1" style="width:294px"><strong>Psychiatric disorders</strong></td><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Insomnia, mood changes (including anxiety), depression</td></tr><tr><td style="text-align:center; width:78px">Rare</td><td style="width:722px">Confusion</td></tr><tr><td rowspan="3" colspan="1" style="width:294px"><strong>Nervous system disorders</strong></td><td style="text-align:center; width:78px">Common</td><td style="width:722px">Somnolence, dizziness, headache (especially at the beginning of the treatment)</td></tr><tr><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Tremor, dysgeusia, syncope, hypoesthesia paresthesia</td></tr><tr><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">Hypertonia, peripheral neuropathy</td></tr><tr><td style="width:294px"><strong>Eye disorders</strong></td><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Visual disturbance (including diplopia)</td></tr><tr><td style="width:294px"><strong>Ear and labyrinth disorders</strong></td><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Tinnitus</td></tr><tr><td rowspan="2" colspan="1" style="width:294px"><strong>Cardiac disorders</strong></td><td style="text-align:center; width:78px">Common</td><td style="width:722px">Palpitations</td></tr><tr><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">Myocardial infarction, arrhythmia(including baradycardia, ventricular tachycardia and atrial fibrillation)</td></tr><tr><td rowspan="3" colspan="1" style="width:294px"><strong>Vascular disorders</strong></td><td style="text-align:center; width:78px">Common</td><td style="width:722px">Flushing</td></tr><tr><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Hypotension</td></tr><tr><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">Vasculitis</td></tr><tr><td rowspan="2" colspan="1" style="width:294px"><strong>Respiratory, thoracic and mediastinal disorders</strong></td><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Dyspnoea, rhinitis</td></tr><tr><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">Cough</td></tr><tr><td rowspan="3" colspan="1" style="width:294px"><strong>Gastrointestinal disorders</strong></td><td style="text-align:center; width:78px">Common</td><td style="width:722px">Abdominal pain, nausea</td></tr><tr><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">Vomiting, dyspepsia, altered bowel habits (including diarrohea and constipation), dry mouth</td></tr><tr><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">Pancreatits, gastritis, gingival hyperplasia</td></tr><tr><td style="width:294px"><strong>Hepatobiliary disorders</strong></td><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">hepatitis, jaundice hepatic enzymes increased*</td></tr><tr><td rowspan="2" colspan="1" style="width:294px"><strong>Skin and subcutaneous tissue disorders</strong></td><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Alopecia, purpura, skin discolouration, hyperhidosis pruritus, rash, exanthema</td></tr><tr><td style="text-align:center; width:78px">Very rare</td><td style="width:722px">Angioedema, erythema multiforme, urticaria, exfoliative dermatitis, Stevnsjohnson syndrome, Quincke oedema, photosensitivity</td></tr><tr><td rowspan="2" colspan="1" style="width:294px"><strong>Musculoskeletal and connective tissue disorders</strong></td><td style="text-align:center; width:78px">Common</td><td style="width:722px">Ankle swelling</td></tr><tr><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Arthralgia, myalgia, muscle cramps, back pain</td></tr><tr><td style="width:294px"><strong>Renal and urinary disorders</strong></td><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Micturition disorder, nocturia, increased urinary frequency</td></tr><tr><td style="width:294px"><strong>Reproductive system and breast disorders</strong></td><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Impotence, gynecomastia</td></tr><tr><td rowspan="2" colspan="1" style="width:294px"><strong>General disorders and administration site conditions</strong></td><td style="text-align:center; width:78px">Common</td><td style="width:722px">Chest pain, asthenia, pain, malaise</td></tr><tr><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Weight increase, weight decrease</td></tr><tr><td style="width:294px"><strong>Investigation</strong></td><td style="text-align:center; width:78px">Uncommon</td><td style="width:722px">Weight increase, weight decrease</td></tr></tbody></table><p>*mostly consistent with cholestasis</p><p>Exceptional cases of extrapyramidal syndrome have been reported.</p><p>a) Description of selected adverse reactions<br />Dizziness: is the feeling of being lightheaded, woozy, or unbalanced. It affects the sensory organs, specifically eyes and ears. It can cause fainting. Dizziness is not a disease but a symptom of other disorders.<br />Headache: a continuous pain in the head<br />Palpitations: a noticeably rapid, strong, or irregular heartbeat due to agitation, exertion, or illness.<br />Flushing: become red and hot, typically as the result of illness or strong emotion.<br />Abdominal pain: Pain in the belly. Abdominal pain can be acute or chronic. It may reflect a major problem with one of the organs in the abdomen.<br />Nausea: a feeling of sickness with an inclination to vomit.<br />Oedema: a condition characterized by an excess of watery fluid collecting in the cavities or tissues of the body.<br />Fatigue: extreme tiredness resulting from mental or physical exertion or illness.</p><p>b) Pediatric Population<br />Safety and efficacy not established in children younger than 6 yr of age.<br />Above 6 years to 17 years adverse events were similar to those seen in adults.</p><p>c) Other special population(s)<br />The following information addresses dosage of amlodipine in special populations.<br />Dosage of drugs administerein fixed combination with amlodipine also may require adjustment in certain patient populations; the need for such dosage adjustment must be considered in the context of cautions, precautions and contraindications specific to that population and drug.</p><p><strong>Hepatic impairment</strong><br />Hyper tension<br />Initially, amlodipine 2.5 mg daily (as initial or add on therapy).</p><p>Angina<br />Initially, amlodipine 5mg daily.</p><p><strong>Renal Impairment</strong><br />Amlodipine dosage modification not necessary.<br />Preparations containing amlodipine in fixed combination with benazepril are not recommended in patients with CIcr &lt;30 ml / minute or Scr &gt; 3 mg /dL</p><p><strong>Geriatric Patients</strong><br />Hypertension<br />Initially amlodipine 2.5 mg daily ( as initial or add &ndash; on therapy) adjust subsequent dosage based on patient response and tolerance.<br />Angina<br />Initially, amlodipine 5mg daily.</p><p>To reports any side effect(s) :<br />&bull; The National Pharmacovigilance Centre (NPC):<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: https://ade.sfda.gov.sa/</p><p>Other GCC States:<br />- Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In human experience with intentional overdose is limited.</p><p>Symptoms<br />Available data suggest that gross over dosage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged systemic hypotension up to and including shock with fatal outcome have been reported.</p><p>Treatment<br />Clinically significant hypotension due to Amlodipine over dosage calls for active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities and attention to circulating fluid volume and urine output.</p><p>A vasoconstrictor may be helpful in restoring vascular tone and blood pressure, provided that there is no contraindication to its use. Intravenous calcium gluconate may be beneficial in reversing the effects of calcium blockade.</p><p>Gastric lavage may be worthwhile in some cases. In healthy volunteers the of charcoal up to 2 hours after administration of Amlodipine 2.5mg, 5mg and 10mg has been shown to reduce the absorption rate of Amlodipine.</p><p>Since Amlodipine is highly protein-bound, dialysis is not likely to be of benefit.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Calcium channel blockers, selective calcium channel blockers with mainly vascular effects. ATC code: C08CA01.<br />Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blockers or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions cardiac and vascular smooth muscle.</p><p>The mechanism of the antihypertensive action of Amlodipine is due o a direct relaxant effect on vascular smooth muscle. The precise mechanism by which Amlodipine relives angina has not been fully determined but Amlodipine reduces total ischemic burden by the following two actions:</p><p>1) Amlodipine dilates peripheral and thus, reduces the total peripheral resistance (after load) against which the heart works. Since the heart rate remains stable, this unloading of the heart reduces myocardial energy consumption and oxygen requirements.</p><p>2) The mechanism of action of amlodipine also probably involves dilatation of the main coronary arteries and coronary arterioles, both in normal and ischemic regions. This dilatation increases myocardial oxygen delivery in patients&rsquo; artery spasm (Prinzmetal&rsquo;s or variant angina).</p><p>In patients with hypertension, once daily dosing provides clinically significant reductions of blood pressure in both the supine and standing positions throughout the 24 hour interval. Due to the slow onset of action, acute hypotension is not a feature of Amlodipine administration.</p><p>In patients with angina, once daily administration of amlodipine increases total exercise time, time to angina onset, and time to 1 mm ST segment depression, and decreases both angina attack frequency and glyceryl trinitrate table consumption.</p><p>Amlodipine has not been associated with any adverse metabolic effects or changes in plasma lipids and is suitable for use in patients with asthma, diabetes, and gout.</p><p>Use in patients with coronary artery disease (CAD)<br />The effectiveness of Amlodipine in preventing clinical events in patients with coronary artery disease (CAD) has been evaluated in an independent, multi-center, randomized, double- blind, placebo controlled study of 1997 patients; Comparison of Amlodipine vs.&nbsp;Enalapril to Limit Occurrences of Thrombosis (CAMELOT). Of these patients, 663 were treated with amlodipine 2.5-5-10 mg were treated with enalaprin 2.5-5.10 mg, and 655 patients were treated with placebo, in addition to standard care of statins, beta-blockers, diuretics and aspirin, for 2 years. The key efficacy results are presented in tablet 1. The results indicate that amlodipine treatment was associated with fewer hospitalizations for angina and revascularization procedures in patients with CAD.</p><table border="1" cellspacing="1" cellpadding="1" align="center" style="width:631px"><caption><strong>Tablet 1. Incidence of significant clinical outcomes for CAMELOT</strong></caption><tbody><tr><td colspan="6" style="text-align:center; width:628px"><u>Cardiovascular event rates.</u></td></tr><tr><td colspan="6" style="text-align:center; width:628px"><u>No. (%)</u>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <u>Amlodipine vs. placebo</u></td></tr><tr><td style="text-align:center; width:224px">Outcomes</td><td style="text-align:center; width:79px">Amlodipine</td><td style="text-align:center; width:85px">Placebo</td><td style="text-align:center; width:59px">Enalapril</td><td style="text-align:center; width:127px">Hazard ratio (95% CI)</td><td style="text-align:center; width:58px"><em>P </em>value</td></tr><tr><td colspan="6" style="text-align:left; width:628px"><u>Primary Endpoint</u></td></tr><tr><td style="width:224px">Adverse cardiovascular events</td><td style="text-align:center; width:79px">110 (16.6)</td><td style="text-align:center; width:85px">151(23.1)</td><td style="text-align:center; width:59px">136(202)</td><td style="text-align:center; width:127px">0.69 (0.54-0.88)</td><td style="text-align:center; width:58px">.003</td></tr><tr><td colspan="6" style="width:628px"><u>Individual Components</u></td></tr><tr><td style="width:224px">Coronary revascularization</td><td style="text-align:center; width:79px">78 (11.8)</td><td style="text-align:center; width:85px">103 (15.7)</td><td style="text-align:center; width:59px">95 (14.1)</td><td style="text-align:center; width:127px">0.58 (0.41-0.82)</td><td style="text-align:center; width:58px">.03</td></tr><tr><td style="width:224px">Hospitalization for angina</td><td style="text-align:center; width:79px">51 (7.7)</td><td style="text-align:center; width:85px">84 (12.8)</td><td style="text-align:center; width:59px">86 (12.8)</td><td style="text-align:center; width:127px">0.58 (0.41-0.82)</td><td style="text-align:center; width:58px">.002</td></tr><tr><td style="width:224px">Nonfatal MI</td><td style="text-align:center; width:79px">14 (2.1)</td><td style="text-align:center; width:85px">19 (2.9)</td><td style="text-align:center; width:59px">11 (1.6)</td><td style="text-align:center; width:127px">0.73 (0.37-1.46)</td><td style="text-align:center; width:58px">.37</td></tr><tr><td style="width:224px">Stroke or TIA</td><td style="text-align:center; width:79px">6 (0.6)</td><td style="text-align:center; width:85px">12 (1.8)</td><td style="text-align:center; width:59px">8 (1.2)</td><td style="text-align:center; width:127px">0.50 (0.19-1.32)</td><td style="text-align:center; width:58px">.15</td></tr><tr><td style="width:224px">Cardiovascular death</td><td style="text-align:center; width:79px">5(0.8)</td><td style="text-align:center; width:85px">2 (0.3)</td><td style="text-align:center; width:59px">5 (0.7)</td><td style="text-align:center; width:127px">2.46 (0.48-12.7)</td><td style="text-align:center; width:58px">.27</td></tr><tr><td style="width:224px">Hospitalization for CHF</td><td style="text-align:center; width:79px">3 (0.5)</td><td style="text-align:center; width:85px">5 (0.8)</td><td style="text-align:center; width:59px">4 (0.6)</td><td style="text-align:center; width:127px">0.59 (0.14-2.47)</td><td style="text-align:center; width:58px">.46</td></tr><tr><td style="width:224px">Resuscitated cardiac arrest</td><td style="text-align:center; width:79px">0</td><td style="text-align:center; width:85px">4 (0.6)</td><td style="text-align:center; width:59px">1 (0.1)</td><td style="text-align:center; width:127px">NA</td><td style="text-align:center; width:58px">.04</td></tr><tr><td style="width:224px">New-onset peripheral&nbsp;Vascular disease</td><td style="text-align:center; width:79px">5 (0.8)</td><td style="text-align:center; width:85px">2 (0.3)</td><td style="text-align:center; width:59px">8 (1.2)</td><td style="text-align:center; width:127px">2.6 (0.50-13.4)</td><td style="text-align:center; width:58px">.24</td></tr></tbody></table><p>Abbreviations: CHF , congestive heart failure; CI, confidence interval; MI, myocardial information; TIA, transient ischemic attack.<br />Us in patients with heart failure<br />Haemodynamic studies and exercise based controlled clinical trials in NYHA Class II-IV heart failure patients have shown that Lodipam did not lead to clinical deterioration as measured by exercise tolerance, left ventricular ejection fraction and clinical symptomatology.</p><p>A placebo controlled study (PRAISE) designed to evaluate patients in NYHA Class III-IV heart failure receiving digoxin, diuretics and ACE inhibitors has shown that Lodipam did not lead to anincrease in risk of mortality or combined mortality and morbidity with heart failure.</p><p>In a follow-up, long term, placebo controlled study (PRAISE-2) of Lodipam in patients with NYHA III and IV heart failure without clinical symptoms or objective findings suggestive or underlying ischaemic disease, on stable doses of ACE inhibitors, diuretics, Lodipam had no effects on total cardiovascular mortality. In this same population Lodipam was associated reports of pulmonary oedema.</p><p><strong><u>Treatment to prevent heart attack trial (ALLHAT)</u></strong><br />A randomized double-blind morbidity-mortality study called the Antihypertensive and Lipid-Lowering Treatment to prevent Heart Attack trial (ALLHAT) was performed to compare newer drug therapies: Amlodipine 2.5, 5 and 10mg (calcium channel blocker) or lisinopril 10-40 mg/d (ACE-inhibitor) as first-line therapies to that of the thiazide-diuretic, chlorthalidone 12.5-25 mg/d in mild to moderate hypertension.&rdquo;</p><p>A total of 33.357 hypertensive patients aged 55 or older were randomized and followed for a mean of 4.9 years. The patients had it least one additional CHD risk factor, including: previous myocardial infarction or stroke (&gt;6 month prior to enrollment) or documentation of other atherosclerotic CVD (overall 51.5%), type 2 diabetes (36.1%), HDL-C&lt;35 mg /DL (11.6%), left ventricular hypertrophy diagnosed by electrocardiogram or echocardiography (20.9%), current smoking (21.9%).</p><p>The primary endpoint was a composite of fatal CHD or non-fatal myocardial infarction. There was no singnificant difference in the primary endpoint between Amlodipine-based therapy and clorthalidone-based therepy: RR 0.98 95% CI (0.90-1.07) p=0.65. Among secondary endpoints, the incidence of heart failure (component of a component combined cardiovascular endpoint) was significantly higher in the amlodipine group as compared to the chlorthalidone group (10.2% vs. 7.7%, RR1.38,95% CI [1.25-1.52] p&lt;0.001). However, there was no significant difference in all-cause mortality between amlodipine-based therapy and chlorthalidone-based therapy. RR 0.95% CI [0.89-1.02] p=0.20.</p><p><u><em>Use in children (aged 6years and older)</em></u><br />In a study involving 268 children aged 6-17 years with predominantly secondary hypertension, comparison of a2.5 mg dose and 5mg dose and 10 mg dose of amlodipine with placebo, showed that both doses reduced systolic Blood pressure significantly more that placebo. The difference between the two doses was not statistically significant.</p><p>The long-time effects of amlodipine on growth, puberty and general development have not been studied. The long-time efficacies of amlodipine on therapy in childhood to reduce cardiovascular morbidity and mortality in adulthood have also not been established.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption, distribution, plasma protein binding:</u> After oral administration of therapeutic doses, amlodipine is well absorbed with peak blood levels 6-12 hours post dose. Absolute bioavailability has been estimated to be between 64 and 80. The volume of distribution is approximately 21 l/kg. In vitro studies have shown that approximately 97.5% of circulating amlodipine is bound to plasma proteins.</p><p>The bioavailability of amlodipine I not affected by food intake.</p><p><em>Biotransformation/ elimination</em><br />The terminal plasma elimination half is about 35-50 hours and is consistent with once daily dosing. Amlodipine is extensively metabolized by the liver to inactive metabolites with 10% of the parent compound and 60% of metabolites excreted in the urine.</p><p><em>Use in hepatic impairment</em><br />Very limited clinical data are available regarding amlodipine administration in patients with hepatic impairment. Patients with hepatic insufficiency have decreased clearance of amlodipine resulting in a longer half-life and an increase in AUC of approximately 40-60%.</p><p><em>Use in the elderly</em><br />The time to reach peak plasma concentrations of amlodipine is similar in elderly and younger subjects. Amlodipine clearance tender to be decreased with resulting increase in AUC and elimination half-life in elderly patients. Increases in AUC and elimination half-life in patients with congestive heart failure were as expected for the patients age group studied.</p><p><em>Use in children</em><br />A population PK study has been conducted in 74 hypertensive children aged from 1 to 17 years (with 34 patients aged 6 to 12 years and 28 patients aged 13 to 17 years) receiving amlodipine between 1.25 and 20 mg given either once or twice daily. In children 6.to 12 years and in adolescents</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Reproductive toxicology<br />Reproductive studies in rats and mice have shown delayed data of delivery, prolonged duration of lab our and decreased pup survival at dosages approximately 50 times greater than the maximum recommended dosage for humans based on mg/kg.</p><p>Impairment of fertility<br />There was no effect on the fertility of rats treated with amlodipine (males for 64 days and females14 days prior to mating) at doses up to 10 mg/kg/day (8 times* the maximum recommended human dose of 10 mg on a mg/m2 basis). In another rat study in which male rats were treated with amlodipine besylate for 30 days at a dose comparable with the human dose based on mg/kg, decreased plasma follicle-stimulating hormone and testosterone were found as well as decreases in sperm density and in the number of mature spermatide and Sertoli cells.</p><p>Carcinogenesis, mutagenesis<br />Rats and mice treated with amlodipine in the diet for two years, at concentrations calculated to provide daily dosage levels of 0.5, 1.25, and 2.5 mg/kg/day showed no evidence of carcinogenicity. The highest dose (for mice, similar to, and for rats twice* the maximum recommended clinical dose of 10 mg on a mg/m2 basis) was close to the maximum tolerated dose for mice but not for rats.</p><p>Mutagenicity studies revealed no drug related effects at either the gene or chromosome levels.</p><p>*Based on patient weight of 50kg</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>2.5 mg, 5 mg, and 10 mg tablets</u><br />Microcrystalline cellulose,<br />Dibasic calcium phosphate anhydrous,<br />Sodium starch glycolate,<br />Magnesium stearate.<br />Opadry white 03F180011 (contains; Titanium dioxide, Hypromellose and Polyethylene glycol)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                5 mg, and 10 mg tablets: 3 years
2.5 mg: 2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>2.5mg, 5 mg, and 10 mg tablets</u><br />Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>2.5 mg tablets</u><br />PVC /Aluminum blisters containing 10 tablets<br /><u>5 mg tablets</u><br />PVC / Aluminum blisters containing 10 tablets<br /><u>10 mg tablets</u><br />PVC / Aluminum blisters containing 10 tablets</p><p>Pack size: 30 tablets (10 tablets x 3 blisters)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance with local requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Saudi Pharmaceutical Industries
P.O.Box No.: 355127,Riyadh 11383
Kingdom of Saudi Arabia.
Tel: (+96611) 2650450, 2650354
Fax: (+96611) 2650383
Email.:info@saudi-pharma.net
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                09/2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>